Blood Collection Devices Global Market Report 2024

Blood collection devices are instrumental in obtaining blood samples from the body, serving purposes in health and wellness testing, population studies, as well as research and preclinical drug studies.

Key categories of blood collection devices encompass blood collection tubes, lancets, micro-container tubes, and warming devices. Blood collection tubes are specifically designed for coagulation investigations and for collecting blood containing sodium citrate. These tubes facilitate the transportation of various blood components to laboratories for testing, playing a crucial role in the diagnostic process. Different types of tests and biochemical assays necessitate specific sample collection tubes. Blood collection devices are manufactured using various materials such as glass, stainless steel, and plastic. They find application in both manual and automatic blood collection processes, serving the needs of hospitals, blood collection centers, diagnostic centers, and other healthcare facilities.

The blood collection devices market research report is one of a series of new reports that provides blood collection devices market statistics, including blood collection devices industry global market size, regional shares, competitors with a blood collection devices market share, detailed blood collection devices market segments, market trends and opportunities, and any further data you may need to thrive in the blood collection devices industry. This blood collection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood collection devices market size has grown strongly in recent years. It will grow from $7.54 billion in 2023 to $8.16 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth observed during the historical period can be attributed to several factors, including the increased prevalence of blood-related disorders, a rise in healthcare infrastructure, the aging population, and government initiatives and regulations.

The blood collection devices market size is expected to see strong growth in the next few years. It will grow to $11.21 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be attributed to factors such as the escalating healthcare expenditure, a heightened emphasis on personalized medicine and diagnostic testing, a surge in research and development activities, and an increase in the prevalence of infectious illnesses. Noteworthy trends expected during this period encompass the adoption of minimally invasive techniques, the emergence of remote blood collection services, the integration of automation and robotics in blood collection processes, the development of advanced blood collection kits, and an increased focus on partnerships and collaborations within the healthcare sector.

The blood collection devices market is experiencing growth driven by the increase in the incidence of infectious diseases. These diseases, caused by various pathogens such as bacteria, viruses, fungi, or parasites, necessitate blood collection and sampling for diagnosis. Infections like hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis are commonly tested through blood collection devices. The continuous rise in the occurrences of infectious diseases and the corresponding need for diagnostic activities are expected to drive the utilization of blood collection devices. As per the World Health Organization (WHO) in 2021, an estimated 10.6 million people globally were infected with tuberculosis, 1.6 million died, and 1.5 million acquired HIV, leading to 650,000 deaths. This surge in infectious diseases is anticipated to contribute to increased demand for blood collection devices in the forecast period.

The growth of the blood collection devices market is expected to be propelled by increasing health awareness. Rising health awareness reflects a growing consciousness and knowledge among individuals and communities about health-related issues, wellness practices, and the significance of maintaining a healthy lifestyle. This heightened awareness often results in informed choices and behaviors aimed at promoting physical, mental, and emotional well-being. It empowers individuals to take control of their health, make informed decisions, and contribute to the overall well-being of communities. In 2022, Mental Health America reported an increase in the percentage of children aged 11 to 17 accessing mental health screenings, highlighting a positive shift towards a more preventive and holistic approach to healthcare. The increasing health awareness is playing a significant role in driving the blood collection devices market.

A key trend gaining popularity in the blood collection devices market is technological advancement. Companies in this market are actively developing new products and technologies to meet the growing demands of the industry and strengthen their global business presence. These technologically advanced products focus on enhancing comfort and providing advanced protection to customers during blood collection procedures. For example, in April 2022, Owen Mumford, a medical device design and manufacturing company, introduced a new venous blood collection portfolio under its Unistik brand. The Unistik ShieldLock Ultra, part of the portfolio, incorporates a one-handed and in-vein activated safety system to reduce the risk of needlestick injuries (NSIs) and features a unique safety mechanism to prevent blood exposure after needle removal, ensuring patient safety, comfort, and quality in venous blood collection. This trend underscores the industry's commitment to innovation and improving the overall blood collection experience.

Major companies in the blood collection devices market are actively engaged in developing innovative products, such as the MiniCollect PIXIE safety lancet. This groundbreaking safety lancet, introduced by Greiner Bio-One, is designed to provide optimal blood flow with a minimal incision depth. The MiniCollect PIXIE employs a pendulum swing mechanism to pierce the skin, creating shallow incisions that breach more capillaries, thereby enhancing the efficiency of blood collection. This technology is particularly beneficial for newborns and premature babies. Launched in June 2021, the MiniCollect PIXIE safety lancet is available in various needle gauges, incision depths, and blade sizes to offer versatility and cater to specific healthcare needs. The product aims to improve the blood collection experience, ensuring minimal discomfort for patients.

In July 2021, Becton, Dickinson and Company (BD), a leading global medical technology company, made an undisclosed acquisition of Velano Vascular. This strategic move allows BD to empower healthcare providers in eliminating multiple needlesticks for blood sample collection, thereby reducing patient pain and discomfort while ensuring quality outcomes and increasing patient satisfaction. Velano Vascular, the acquired company, is a US-based medical equipment manufacturer dedicated to enhancing both inpatient blood collection and vascular access. This acquisition underscores the industry trend of major companies expanding their capabilities and product offerings through strategic partnerships and acquisitions, ultimately focusing on improving patient care and experience in blood collection procedures.

Major companies operating in the blood collection devices market include Becton, Dickinson and Company, Greiner Holding AG, Kabe Labortechnik GmbH, Sarstedt AG & Company, ICU Medical Inc., Terumo BCT Inc., Fresenius Kabi AG, Grifols S.A., Haematonics, Nipro Medical Corporation, Quest Diagnostics Incorporated, Macopharma SA, Smiths Medical International Ltd., Cardinal Health Inc., Retractable Technologies Inc., Sekisui Medical Co. Ltd., Qiagen NV, Smiths Group PLC, NIPRO Corporation, PT. Adi Buana Mandiri, Covidien Ltd., Kawasumi Laboratories Inc., F.L. Medical SRL, Ajosha Bio Teknik Pvt. Ltd., A-M Systems Ltd., Commonwealth Serum Laboratories Behring, Teleflex Medical Inc., Abbott Laboratories, Denova Sciences Pte. Ltd., VedaLab SA

North America was the largest region in the blood collection devices market in 2023. The Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood collection devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the blood collection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The blood collection devices market consists of sales of blood collection tubes, needles and syringes, blood bags, blood collection systems, and lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.